These effects, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two support the thought of focusing on ACKR3 as a novel way to modulate the opioid program, which could open new therapeutic avenues for opioid-relevant disorders. In response to this concern, https://miltonp616haq3.wikisona.com/user